Home » Alumni Resources » Elluminate Lecture Series

Elluminate Lecture Series

Click on presentation title to access session recording.

From the Dogon Country to Pol Pot’s Lair

Chris Plowe, M.D., M.P.H., Professor at the University of Maryland School of Medicine and Chief of the Malaria Section of the University’s Center for Vaccine Development, talks about his work with malaria in Mali.

Epidemiology in Transition in China: Opportunities and Challenges

Xiao-Ou Shu, M.D., M.P.H., Ph.D., Professor and Cancer Epidemiologist at Vanderbilt University, talks about her current work in China.  Dr. Shu investigates the epidemiology of cancer and chronic disease in large population-based, cohort studies.

Clinical Trials

Marshall Glesby, M.D., Ph.D., Associate Professor of Medicine Associate Chief of the Division of Infectious Diseases at Weill Cornell Medical College, talks about clinical trial methodology. His primary research focus is metabolic complications of HIV disease and its therapy.  Dr. Glesby co-directs the Clinical Trials Design and Analysis course of the Weill K30 funded Masters in Clinical Investigation program.

Complications of Antiretroviral Therapy in Resource-Limited Settings

Yukari Manabe, M.D., Associate Professor in the Division of Infectious Diseases at Johns Hopkins Medicine and the John Hopkins Bloomberg School of Public Health, talks about her work with HIV and TB in Uganda.  Her research and professional experience are in the areas of infectious disease, including TB-HIV co-infection

CNS Infections

Joe Zunt, M.D., M.P.H., Associate Professor of Neurology and of Global Health, Adjunct Associate Professor of Epidemiology, will make an Elluminate presentation on “CNS Infections”.  Dr. Zunt directs a numbers of training activities in Peru for a number of training programs.  His expertise includes work in retroviral infections, infections in the nervous system, commercial sex work, and pediatric/adolescent health.

Mother-to-child HIV transmission in resource-limited settings

Carey Farquhar, M.D., M.P.H., Associate Professor of Medicine, Epidemiology, and Global Health at the University of Washington and Director of IARTP at UW, will present on Mother-to-child HIV transmission in resource-limited settings.  Dr. Farquhar is interested in AIDS epidemiology and HIV prevention in Africa as well as heterosexual and vertical HIV transmission.

Life Under the Junta: Evidence of Crimes Against Humanity in Burma’s Chin State

Chris Beyrer, M.D., M.P.H., PI of the Chiang Mai University site, will give his presentation on human rights work in the Thai-Burma zone. Dr. Beyrer’s research and professional experience includes HIV/AIDS preventive interventions, including HIV vaccine clinical trials and preparedness studies; epidemiology and molecular epidemiology of HIV; substance use and narcotics research; and public health and human rights.

Human Papillomavirus Vaccines: Current Status and Future Prospects for HIV Prevention?

Jennifer Smith, PI of the Cancer Institute and Hospital of the Chinese Academy of Medical Sciences (CICAMS) site in Beijing, China will give a presentation on “Human Papillomavirus Vaccines: Current Status and Future Prospects for HIV Prevention?” Dr. Smith’s current research focuses on epidemiological studies of human papillomavirus (HPV) and cervical cancer worldwide (primarily in North Carolina, China, and Kenya), with a focus on prevention via screening or prophylactic HPV vaccines, and on the sero-epidemiology of herpes simplex virus infections.

Protective Immunity to Human Cholera – Studies from Fogarty Students

Stephen Calderwood, M.D., PI of the International Centre for Diarrhoeal Disease Research, Bangladesh: Laboratory Sciences Division in Dhaka, Bangladesh will give a talk on “Protective Immunity to Human Cholera – Studies from Fogarty Students”. His clinical interests are in bacterial gastroenteritis, endocarditis, meningitis, and general infectious disease with research interests in cholera and cholera vaccines.

Update on PrEP Trials

Kenneth Mayer, M.D., Professor of Medicine & Community Health at Brown University; Director of the Brown University AIDS Program; Adjunct Professor at the Harvard School of Public Health, will present an Update on PrEP Trials.  Dr. Mayer has a long history of working in HIV prevention and vaccine research, both in the U.S. and abroad.

A Veterinary Perspective of Global Health

Daphne Carlson-Bremer, D.V.M., M.P.V.M., Fellow at the Vanderbilt Institute of Global Health, talks about her work studying the linkages between veterinary development and health, social, and economic outcomes for humans in Mozambique. Her doctorate research has focused on the epidemiology of protozoal parasites in California seat lions.  Prior to completing her work on her master’s degree, Dr. Carlson-Bremer practiced veterinary medicine in Houston and Berkeley for five years.

Bringing your Fogarty Lessons Home; Transitioning after Your Fogarty Year

Joseph Tucker, M.D., Postdoctoral Research Fellow at the the UNC School of Medicine, Massachusetts General Hospital/Brigham and Women’s Hospital, and Fogarty Fellow in Nanjing, China 2008-2009, will present on “Bringing your Fogarty Lessons Home; Transitioning after Your Fogarty Year”. Dr. Tucker has research interests in syphilis and HIV in China, the implementation of routine syphilis/HIV testing, particularly as they relate to Chinese social structures.  As a Fogarty Fellow in Nanjing, China in 2008-2009, Dr. Tucker studied STI clinician attitudes in South China.  Dr. Tucker will speak about his experience returning to the U.S. following his Fogarty year.

Polio Eradication

Peter Wright, MD, Professor of pediatrics at the Dartmouth-Hitchcock Medical Center, discusses Polio Eradication and his experience in Haiti. Dr. Wright is an ambassador to the Paul G. Rogers Society for Global Health, and continues to split his time between Haiti, Nashville, and Vermont.

Road Traffic Injuries: A Global Health Challenge

Myat Htoo Razak, PhD, MBBS, Dr. Razak is the Program Director of the Fogarty International Clinical Research Training for Scholars and Fellows Program, and the Fogarty International Collaborative Trauma and Injury Research Training Program of the Fogarty International Center (FIC), the U.S. National Institutes of Health (NIH). Both programs focus on research capacity building and strengthening global health research networks for health professionals from the U.S. and developing countries in Africa, Asia and Latin America. In addition, Dr. Razak is the FIC Program Team Leader of the Medical Education Partnership Initiative (MEPI), a joint-program funded by the President’s Emergency Plan for AIDS Relief (PEPFAR) and NIH that aims to provide support to improve quantity, quality and retention of health professionals in Africa. He has more than 20 years of experience in clinical services, epidemiology, HIV/AIDS research and intervention, global health capacity building and health systems strengthening.

The HIV Neurology in Kenya (THINK) Study: Results from Pilot Testing

Ana-Claire Meyer, MD, MSHS, was a 2009-2010 Fogarty Fellow. She is currently an Assistant Professor of neurology at the University of California San Francisco, where she continues to work with KEMRI and FACES Kenya.

Changing Spectrum of CVD in Sub-Saharan Africa

Gerald Bloomfield, MD, completed the Duke Global Health Fellowship Pathway and a Fogarty International Clinical Research Fellowship in 2010 and is currently Assistant Professor of Medicine and Global Health at the Duke University Medical Center. Dr Bloomfield continues his work in Eldoret, Kenya at Moi University to determine the local contemporary causes of heart failure and to help establish an NHLBI-funded cardiovascular Center of Excellence at Moi.

Domestic and Global Evolution of HIV Prevention and Treatment Guidelines – Practical Implications

Paul Palumbo, MD, Director, International Pediatric HIV Program, Dartmouth-Hitchcok Medical Center.

The Influence of Infectious Diseases on Cancer in Malawi

Elizabeth Bigger, MD, was a 2009-2010 Fogarty Fellow. She is currently a second year Hematology-Oncology Fellow at Duke University.

HIV/HSV-2 Co-infection and Immune Activation: Impact of Valacyclovir on Women’s Health

Alison Roxby, MD, MSc, 2009-2011 Fogarty Fellow, received her MD degree from UNC-Chapel Hill and a Master’s in Public Health from the London School of Hygiene and Tropical Medicine. She has worked in 5 different African countries to improve access to HIV care and prevent HIV transmission. After completing a residency in internal medicine at Stanford, she came to UW in 2007 for Infectious Disease fellowship and to work with the Kenya Research Program under the mentorship of Carey Farquhar. Alison and her family returned in 2010 from 18 months in Nairobi, where she was the study physician for the Valacyclovir in Pregnancy trial, a clinical trial of valacyclovir in pregnant women co-infected with HIV and HSV-2. She also collected data on immune activation in pregnant women. Alison’s ongoing research goals are to improve maternal health, promote family planning, and reduce perinatal transmission of HIV. She also sees adult HIV patients at Roosevelt Clinic, and Madison Clinic.

Viral Respiratory Infections in Honduran Children

Elizabeth Schlaudecker, MD, MPH, is a faculty member in the Division of Infectious Diseases and the Global Health Center. Dr. Schlaudecker received her medical degree and master’s in public health from the University of Cincinnati and completed a pediatrics residency and chief residency at Cincinnati Children’s. Dr. Schlaudecker was awarded a Fogarty International Clinical Research Fellowship from the National Institutes of Health in 2009, and she investigated the etiology and seasonality of viral respiratory disease in Honduran children under the age of five. She was awarded the Pediatric Infectious Diseases Society Blue Ribbon Research award in 2011 for similar work in Bangladesh. After joining the faculty of Cincinnati Children’s in 2011, she continued her influenza research with a Procter Scholars award. Dr. Schlaudecker has traveled to Honduras, the Dominican Republic, Costa Rica, Ecuador, Kenya, South Africa, and Cameroon as part of her clinical and research training.

TB co-infection in HIV-infected children in Kenya: dividing brothers and sisters

Lisa Dillabaugh, MD, is currently an assistant adjunct professor in the Department of Pediatrics, Division of Infectious Disease. Concurrently, she serves as deputy country director for family AIDS Care and Education Services (FACES) in Kenya. Throughout her training and early career she has shown a commitment to child health and global health initiatives. She was a UCSF Global Health clinical scholar (2006-2008) and a Fogarty International Health Clinical Fellow (2009-2010). Her primary academic interests include global health program implementation and research in pediatric HIV/AIDS.


Clive Gray, PhD, founder of Immunopaedia, is a Chief Specialist Scientist and Head of Department of HIV Immunology at the National Institute for Communicable Diseases, Johannesburg, South Africa. In 2004 he was the recipient of the Elizabeth Glaser AIDS Pediatric Foundation International Leadership Award. This was a three-year grant to fund Immunopaedia (www.immunopaedia.org), which uses a case study-centered approach to immunology learning and to understand the impact of HIV and other infectious diseases on the pediatric immune system.

Cervical Cancer Prevention in Resource Limited Settings: Experiences from Zambia

Sten Vermund, MD, PhD, Director Vanderbilt Institute for Global Health, is an infectious disease epidemiologist and a pediatrician with clinical and research experience in adolescent and women’s health that dovetailed into the HIV/AIDS field in the late 1980s. Now at Vanderbilt University, he is PI for several training and research grants from the NIH and CDC, including two projects under the President’s Emergency Plan for AIDS Relief. Sten serves as PI for the HIV Prevention Trials Network and he directs the Vanderbilt University Institute for Global Health as its Amos Christie Chair in Global Health and Professor of Pediatrics. Dr. Vermund served as the PI of the FICRS-F Support Center and is currently PI of the VECD Global Health Fellows Consortium.

Rotovirus Vaccine Development

Roger Glass, MD, MPH, Director Fogarty International Center, has served as the Director of the Fogarty International Center and Associate Director for International Research at NIH since 2006. Dr. Glass’s research interests are in the prevention of gastroenteritis from rotaviruses and nonviruses through the application of novel scientific research. He has maintained field studies in India, Bangladesh, Brazil, Mexico, Israel, Russia, Vietnam, China and elsewhere. His research has been targeted toward epidemiologic studies to anticipate the introduction of rotavirus vaccines.

HIV Test and Treat

Sten Vermund, MD, PhD, describes HIV Test and Treat.


Timothy Sterling, MD, Department of Infectious Disease, Vanderbilt University.

Effectiveness and Potential Impact of Tenofovir Gel

Quarraisha Abdool Karim, PhD, is an infectious diseases epidemiologist whose main research interests are in understanding the evolving HIV epidemic in South Africa; factors influencing acquisition of HIV infection in adolescent girls; and sustainable strategies to introduce HAART in resource-constrained settings. In addition to being a member of the faculty at the Mailman School, Dr. Abdool Karim is an associate professor in Public Health and Family Medicine at the Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, South Africa.

HOPE Online Network & Hepatitis B and HIV co-infection

Rajesh Gandhi, MD, is Associate Professor of Medicine at Harvard Medical School and Director of HIV Clinical Services and Education at Massachusetts General Hospital. He is the site leader of the Massachusetts General Hospital AIDS Clinical Trials Site in the Harvard/Boston Medical Center/Miriam AIDS Clinical Trials Unit. He is also the Director of the Harvard University Center for AIDS Research (CFAR) Clinical Core. He is the editor of Partners ID Images, an educational infectious diseases website, and organizer of the HIV Online Provider Education (HOPE) program, which is an Internet-based educational conference series for physicians caring for HIV-infected patients in resource-limited settings. His research interests are in clinical trials of immune-based therapies for HIV and in HIV/viral hepatitis coinfection.

Diagnosis and Treatment of Cryptococcal Meningitis

Charles van der Horst, MD, FACP, has been conducting clinical trials in the treatment and prevention of HIV, opportunistic infections (CMV, PCP, MAC, Cryptococcus, adenovirus), EBV and influenza since 1982. Since 2001 he has also worked in Malawi and South Africa with a focus on prevention of mother to child transmission of HIV, treatment of cryptococcal meningitis and operations research on better methods to prevent and treat HIV in the resource constrained setting. His research is currently focused on randomized clinical trials to treat infections in Malawi and North Carolina as well as studying better methods to implement programs on prevention of mother to child transmission of HIV in Malawi.

Prevention of HIV-1 and Antiretroviral Agents

Myron S. Cohen, MD, is the PI of the China Center for Disease Control (China CDC) National Center for STD and Leprosy Control (NCSTD) site for Scholars. He is also J. Herbert Bate Distinguished Professor of Medicine, Microbiology and Im­munology and Public Health at the University of North Carolina at Chapel Hill. He is Associate Vice Chancellor for Medical Affairs-Global Health. He received his B.S. degree (magna cum laude) from the University of Illinois, Champaign-Urbana, an M.D. degree from Rush Medical College, Chicago Illinois, and completed an Infectious Disease Fellowship at Yale University. Dr. Cohen serves as the Director of the UNC Division of Infectious Disease and the UNC Institute for Global Health and Infectious Disease and also serves as Associate Director of the UNC Center for AIDS Research. Additionally, Dr. Cohen serves on the Senior Leadership Group of the NIH Center for HIV Vaccine Immunology (CHAVI), serves as part of the leadership group of the NIH HIV Prevention Trials Network (HPTN), and as an Associate Editor of the journal Sexually Transmitted Diseases and the comprehensive textbook Sexually Transmitted Diseases. He received the Thomas Parran Award (2005) for lifetime achievement in STD research from the American Sexually Transmitted Diseases Association. In 2008 he received the O. Max Gardner Award for “contributions to mankind,” the greatest honor in the University of North Carolina’s 16-campus system. Dr. Cohen’s research work focuses on the transmission and prevention of transmission of HIV, with emphasis on the role played by STD co-infections. He has conducted landmark studies related to the biology of HIV transmission, and use of antiretroviral agents for prevention. In 2005, Dr. Cohen received an NIH MERIT Award for ongoing support of this work. Much of Dr. Cohen’s research has been conducted in resource-constrained countries, especially in Malawi and in the People’s Repub­lic of China.

TB Active Case Finding in western Kenya

E. Jane Carter, MD, focuses on Tuberculosis Program Development and Care Delivery. TB is both the leading killer from a single infectious agent in the world as well as the leading cause of death in patients living with HIV globally. 5ooo die daily. Her work focuses both locally is at the RI TB Clinic as well as internationally (primarily in Kenya) to develope community based care programs, promote DOTS expansion,new TB diagnostics for the developing world and coordinated care progams for TB/HIV.